HEADER HYDROLASE 18-AUG-04 1WOF TITLE CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.24.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_TAXID: 227859; SOURCE 4 STRAIN: BJ01; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS ANTI-PARALLEL B-BARREL, ANTI-PARALLEL A-HELICES, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.YANG,M.BARTLAM,X.XUE,K.YANG,W.LIANG,Z.RAO REVDAT 4 30-OCT-24 1WOF 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1WOF 1 VERSN REVDAT 2 04-OCT-05 1WOF 1 JRNL REVDAT 1 30-AUG-05 1WOF 0 JRNL AUTH H.YANG,W.XIE,X.XUE,K.YANG,J.MA,W.LIANG,Q.ZHAO,Z.ZHOU,D.PEI, JRNL AUTH 2 J.ZIEBUHR,R.HILGENFELD,K.Y.YUEN,L.WONG,G.GAO,S.CHEN,Z.CHEN, JRNL AUTH 3 D.MA,M.BARTLAM,Z.RAO JRNL TITL DESIGN OF WIDE-SPECTRUM INHIBITORS TARGETING CORONAVIRUS JRNL TITL 2 MAIN PROTEASES. JRNL REF PLOS BIOL. V. 3 324 2005 JRNL REFN ISSN 1544-9173 JRNL PMID 16128623 JRNL DOI 10.1371/JOURNAL.PBIO.0030324 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 39635 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2093 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4732 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.890 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WOF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1000023812. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42325 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MES, DMSO, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.67250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 GLN A 306 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 LEU B -2 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 465 GLN B 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 1 -75.92 -42.91 REMARK 500 ASP A 33 -134.25 51.12 REMARK 500 ASP A 34 38.32 -97.72 REMARK 500 HIS A 41 5.48 -66.38 REMARK 500 ASN A 51 68.75 -159.17 REMARK 500 ASN A 84 -121.48 60.77 REMARK 500 TYR A 154 -93.42 79.47 REMARK 500 ASP B 33 -123.96 54.94 REMARK 500 ASN B 84 -123.29 52.90 REMARK 500 HIS B 134 -2.15 77.90 REMARK 500 TYR B 154 -107.04 67.46 REMARK 500 SER B 301 56.75 -157.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 A 1145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 B 2145 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UJ1 RELATED DB: PDB REMARK 900 RELATED ID: 1WNO RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AN INHIBITOR I2 DBREF 1WOF A 1 306 UNP P59641 R1AB_CVHSA 3241 3546 DBREF 1WOF B 1 306 UNP P59641 R1AB_CVHSA 3241 3546 SEQADV 1WOF GLY A -4 UNP P59641 CLONING ARTIFACT SEQADV 1WOF PRO A -3 UNP P59641 CLONING ARTIFACT SEQADV 1WOF LEU A -2 UNP P59641 CLONING ARTIFACT SEQADV 1WOF GLY A -1 UNP P59641 CLONING ARTIFACT SEQADV 1WOF SER A 0 UNP P59641 CLONING ARTIFACT SEQADV 1WOF GLY B -4 UNP P59641 CLONING ARTIFACT SEQADV 1WOF PRO B -3 UNP P59641 CLONING ARTIFACT SEQADV 1WOF LEU B -2 UNP P59641 CLONING ARTIFACT SEQADV 1WOF GLY B -1 UNP P59641 CLONING ARTIFACT SEQADV 1WOF SER B 0 UNP P59641 CLONING ARTIFACT SEQRES 1 A 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 A 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 A 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 A 311 THR VAL TYR CYS PRO ARG HIS VAL ILE CYS THR ALA GLU SEQRES 5 A 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 A 311 LYS SER ASN HIS SER PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 A 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS LEU SEQRES 8 A 311 LEU ARG LEU LYS VAL ASP THR SER ASN PRO LYS THR PRO SEQRES 9 A 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 A 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 A 311 TYR GLN CYS ALA MET ARG PRO ASN HIS THR ILE LYS GLY SEQRES 12 A 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 A 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 A 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 A 311 GLU GLY LYS PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 A 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR LEU ASN SEQRES 17 A 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 A 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 A 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 A 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 A 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA ALA LEU SEQRES 22 A 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 A 311 LEU GLY SER THR ILE LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 A 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 B 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 B 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 B 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 B 311 THR VAL TYR CYS PRO ARG HIS VAL ILE CYS THR ALA GLU SEQRES 5 B 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 B 311 LYS SER ASN HIS SER PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 B 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS LEU SEQRES 8 B 311 LEU ARG LEU LYS VAL ASP THR SER ASN PRO LYS THR PRO SEQRES 9 B 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 B 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 B 311 TYR GLN CYS ALA MET ARG PRO ASN HIS THR ILE LYS GLY SEQRES 12 B 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 B 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 B 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 B 311 GLU GLY LYS PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 B 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR LEU ASN SEQRES 17 B 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 B 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 B 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 B 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 B 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA ALA LEU SEQRES 22 B 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 B 311 LEU GLY SER THR ILE LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 B 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN HET I12 A1145 44 HET I12 B2145 44 HETNAM I12 N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]-L-ALANYL-L-VALYL- HETNAM 2 I12 N~1~-((1S)-4-ETHOXY-4-OXO-1-{[(3S)-2-OXOPYRROLIDIN-3- HETNAM 3 I12 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE HETSYN I12 (E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5- HETSYN 2 I12 METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}- HETSYN 3 I12 BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO- HETSYN 4 I12 PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER FORMUL 3 I12 2(C30 H46 N6 O8) FORMUL 5 HOH *231(H2 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 CYS A 44 5 4 HELIX 3 3 THR A 45 LEU A 50 5 6 HELIX 4 4 ASN A 53 ARG A 60 1 8 HELIX 5 5 SER A 62 HIS A 64 5 3 HELIX 6 6 ILE A 200 ASN A 214 1 15 HELIX 7 7 THR A 226 MET A 235 1 10 HELIX 8 8 LYS A 236 ASN A 238 5 3 HELIX 9 9 THR A 243 LEU A 250 1 8 HELIX 10 10 LEU A 250 GLY A 258 1 9 HELIX 11 11 ALA A 260 GLY A 275 1 16 HELIX 12 12 THR A 292 GLY A 302 1 11 HELIX 13 13 SER B 10 GLY B 15 1 6 HELIX 14 14 HIS B 41 CYS B 44 5 4 HELIX 15 15 ASN B 53 ARG B 60 1 8 HELIX 16 16 SER B 62 HIS B 64 5 3 HELIX 17 17 ILE B 200 ASN B 214 1 15 HELIX 18 18 THR B 226 MET B 235 1 10 HELIX 19 19 LYS B 236 ASN B 238 5 3 HELIX 20 20 THR B 243 LEU B 250 1 8 HELIX 21 21 LEU B 250 GLY B 258 1 9 HELIX 22 22 ALA B 260 GLY B 275 1 16 HELIX 23 23 THR B 292 SER B 301 1 10 SHEET 1 A 7 VAL A 73 LEU A 75 0 SHEET 2 A 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 A 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 A 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 THR A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 A 7 LEU A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 A 7 VAL A 77 GLN A 83 -1 N SER A 81 O ARG A 88 SHEET 1 B 5 TYR A 101 PHE A 103 0 SHEET 2 B 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 B 5 VAL A 148 ASP A 153 -1 N ASP A 153 O CYS A 156 SHEET 4 B 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 B 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 C 3 TYR A 101 PHE A 103 0 SHEET 2 C 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 C 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 D 7 VAL B 73 LEU B 75 0 SHEET 2 D 7 PHE B 66 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 D 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 D 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 D 7 THR B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 LEU B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 D 7 VAL B 77 GLN B 83 -1 N SER B 81 O ARG B 88 SHEET 1 E 5 LYS B 100 PHE B 103 0 SHEET 2 E 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 E 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 E 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 E 5 SER B 121 ALA B 129 -1 O TYR B 126 N VAL B 114 SHEET 1 F 3 LYS B 100 PHE B 103 0 SHEET 2 F 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 F 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C21 I12 A1145 1555 1555 1.81 LINK SG CYS B 145 C21 I12 B2145 1555 1555 1.80 SITE 1 AC1 22 THR A 25 THR A 26 HIS A 41 MET A 49 SITE 2 AC1 22 PHE A 140 ASN A 142 GLY A 143 SER A 144 SITE 3 AC1 22 CYS A 145 HIS A 163 HIS A 164 MET A 165 SITE 4 AC1 22 GLU A 166 HIS A 172 ASP A 187 ARG A 188 SITE 5 AC1 22 GLN A 189 THR A 190 ALA A 191 GLN A 192 SITE 6 AC1 22 HOH A1257 HOH A1258 SITE 1 AC2 18 THR B 26 HIS B 41 PHE B 140 ASN B 142 SITE 2 AC2 18 GLY B 143 SER B 144 CYS B 145 HIS B 163 SITE 3 AC2 18 HIS B 164 MET B 165 GLU B 166 PRO B 168 SITE 4 AC2 18 HIS B 172 ASP B 187 GLN B 189 THR B 190 SITE 5 AC2 18 ALA B 191 HOH B2259 CRYST1 51.683 95.345 67.530 90.00 103.57 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019349 0.000000 0.004672 0.00000 SCALE2 0.000000 0.010488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015234 0.00000